78 related articles for article (PubMed ID: 20831257)
1. Improving protein pharmacokinetics by engineering erythrocyte affinity.
Kontos S; Hubbell JA
Mol Pharm; 2010 Dec; 7(6):2141-7. PubMed ID: 20831257
[TBL] [Abstract][Full Text] [Related]
2. Engineering human IgG1 affinity to human neonatal Fc receptor: impact of affinity improvement on pharmacokinetics in primates.
Yeung YA; Leabman MK; Marvin JS; Qiu J; Adams CW; Lien S; Starovasnik MA; Lowman HB
J Immunol; 2009 Jun; 182(12):7663-71. PubMed ID: 19494290
[TBL] [Abstract][Full Text] [Related]
3. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.
Hoare SR; Sullivan SK; Schwarz DA; Ling N; Vale WW; Crowe PD; Grigoriadis DE
Biochemistry; 2004 Apr; 43(13):3996-4011. PubMed ID: 15049707
[TBL] [Abstract][Full Text] [Related]
4. Anti-serum albumin domain antibodies for extending the half-lives of short lived drugs.
Holt LJ; Basran A; Jones K; Chorlton J; Jespers LS; Brewis ND; Tomlinson IM
Protein Eng Des Sel; 2008 May; 21(5):283-8. PubMed ID: 18387938
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle Attachment to Erythrocyte Via the Glycophorin A Targeted ERY1 Ligand Enhances Binding without Impacting Cellular Function.
Sahoo K; Koralege RS; Flynn N; Koteeswaran S; Clark P; Hartson S; Liu J; Ramsey JD; Pope C; Ranjan A
Pharm Res; 2016 May; 33(5):1191-203. PubMed ID: 26812966
[TBL] [Abstract][Full Text] [Related]
6. Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR.
Suzuki T; Ishii-Watabe A; Tada M; Kobayashi T; Kanayasu-Toyoda T; Kawanishi T; Yamaguchi T
J Immunol; 2010 Feb; 184(4):1968-76. PubMed ID: 20083659
[TBL] [Abstract][Full Text] [Related]
7. Structures of phage-display peptides that bind to the malarial surface protein, apical membrane antigen 1, and block erythrocyte invasion.
Keizer DW; Miles LA; Li F; Nair M; Anders RF; Coley AM; Foley M; Norton RS
Biochemistry; 2003 Aug; 42(33):9915-23. PubMed ID: 12924940
[TBL] [Abstract][Full Text] [Related]
8. Peptide tags for enhanced cellular and protein adhesion to single-crystalline sapphire.
Krauland EM; Peelle BR; Wittrup KD; Belcher AM
Biotechnol Bioeng; 2007 Aug; 97(5):1009-20. PubMed ID: 17238208
[TBL] [Abstract][Full Text] [Related]
9. Structure-based design of an agonistic peptide targeting Fas.
Yoshimori A; Takasawa R; Hayakawa A; Mizuno M; Yoshida J; Tanuma S
Apoptosis; 2005 Mar; 10(2):323-9. PubMed ID: 15843893
[TBL] [Abstract][Full Text] [Related]
10. Peptides from the Plasmodium falciparum STEVOR putative protein bind with high affinity to normal human red blood cells.
García JE; Puentes A; Curtidor H; Vera R; Rodriguez L; Valbuena J; López R; Ocampo M; Cortés J; Vanegas M; Rosas J; Reyes C; Patarroyo ME
Peptides; 2005 Jul; 26(7):1133-43. PubMed ID: 15949631
[TBL] [Abstract][Full Text] [Related]
11. Engineering, cloning, and functional characterization of recombinant LIM mineralization protein-1 containing an N-terminal HIV-derived membrane transduction domain.
Sangadala S; Okada M; Liu Y; Viggeswarapu M; Titus L; Boden SD
Protein Expr Purif; 2009 Jun; 65(2):165-73. PubMed ID: 19284982
[TBL] [Abstract][Full Text] [Related]
12. Engineering a pharmacologically superior form of granulocyte-colony-stimulating factor by fusion with gelatin-like-protein polymer.
Huang YS; Wen XF; Wu YL; Wang YF; Fan M; Yang ZY; Liu W; Zhou LF
Eur J Pharm Biopharm; 2010 Mar; 74(3):435-41. PubMed ID: 19995603
[TBL] [Abstract][Full Text] [Related]
13. Site-specific polysialylation of an antitumor single-chain Fv fragment.
Constantinou A; Epenetos AA; Hreczuk-Hirst D; Jain S; Wright M; Chester KA; Deonarain MP
Bioconjug Chem; 2009 May; 20(5):924-31. PubMed ID: 19402707
[TBL] [Abstract][Full Text] [Related]
14. Designing scaffolds of peptides for phage display libraries.
Uchiyama F; Tanaka Y; Minari Y; Tokui N
J Biosci Bioeng; 2005 May; 99(5):448-56. PubMed ID: 16233816
[TBL] [Abstract][Full Text] [Related]
15. A family of leukemia inhibitory factor-binding peptides that can act as antagonists when conjugated to poly(ethylene glycol).
Fairlie WD; Uboldi AD; Hemmings GJ; Smith BJ; Martin HM; Morgan PO; Baca M
Biochemistry; 2003 Nov; 42(45):13193-201. PubMed ID: 14609330
[TBL] [Abstract][Full Text] [Related]
16. Binding specificities of eight monoclonal antibodies to human glycophorin A--studies with McM, and MkEn(UK) variant human erythrocytes and M- and MNV-type chimpanzee erythrocytes.
Bigbee WL; Langlois RG; Vanderlaan M; Jensen RH
J Immunol; 1984 Dec; 133(6):3149-55. PubMed ID: 6491283
[TBL] [Abstract][Full Text] [Related]
17. Quantification of PDZ domain specificity, prediction of ligand affinity and rational design of super-binding peptides.
Wiedemann U; Boisguerin P; Leben R; Leitner D; Krause G; Moelling K; Volkmer-Engert R; Oschkinat H
J Mol Biol; 2004 Oct; 343(3):703-18. PubMed ID: 15465056
[TBL] [Abstract][Full Text] [Related]
18. Directed evolution of soluble single-chain human class II MHC molecules.
Esteban O; Zhao H
J Mol Biol; 2004 Jun; 340(1):81-95. PubMed ID: 15184024
[TBL] [Abstract][Full Text] [Related]
19. Engineering high affinity superantigens by phage display.
Enever C; Tomlinson IM; Lund J; Levens M; Holliger P
J Mol Biol; 2005 Mar; 347(1):107-20. PubMed ID: 15733921
[TBL] [Abstract][Full Text] [Related]
20. Structural modifications to a high-activity binding peptide located within the PfEMP1 NTS domain induce protection against P. falciparum malaria in Aotus monkeys.
Curtidor H; Torres MH; Alba MP; Patarroyo ME
Biol Chem; 2007 Jan; 388(1):25-36. PubMed ID: 17214546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
